Mass Balance and Biotransformation Study of [14C]DBPR108 in Human

Clinical trial NCT05072028 · COMPLETED

Trial details

NCT number: NCT05072028
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Male Subjects

Start date: 2021-11-16
Primary completion: 2021-11-28
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.